POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.

Congressional Hearing: Member Day on the Opioid Crisis

Original title: MEMBER DAY: TESTIMONY AND PROPOSALS ON THE OPIOID CRISIS

Record date · January 1, 2018

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This document is a transcript of a '' hearing held by the House Subcommittee on Health on October 11, 2017. During this session, various members of Congress presented testimony and legislative proposals aimed at addressing the national opioid epidemic.

Why it matters

This hearing served as a formal platform for members of Congress to propose legislative solutions to the opioid crisis, which influences the development of future federal health policy and funding priorities.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Members of Congress

Members participated by providing testimony and legislative proposals for consideration by the subcommittee.

Directly affected

House Subcommittee on Health

The subcommittee organized and conducted the hearing to inform future legislative action.

Key Facts

  • The hearing was held on October 11, 2017, by the House Subcommittee on Health.
  • The purpose of the hearing was to receive testimony and proposals from members of Congress regarding the opioid crisis.
  • The hearing is identified as Serial No. 115-64.
  • Numerous members of Congress, including committee leadership and other representatives, submitted prepared statements and testimony.
Show all 5 facts
  • The proceedings were conducted under the authority of the Committee on Energy and Commerce.

Frequently Asked Questions

What is a 'Member Day' hearing?
A hearing is a session where members of Congress who are not necessarily on the specific subcommittee are invited to present their own legislative proposals or testimony on a specific topic.
What was the primary focus of this hearing?
The hearing focused on gathering legislative ideas and testimony to address the opioid crisis in the United States.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Broad Congressional Engagement

The hearing format allowed for a wide range of members from different states to contribute, indicating a broad legislative interest in opioid policy at the time.

Connected Entities

House Subcommittee on Health, Greg Walden, Gene Green and 2 more
OrganizationHouse Subcommittee on Health“The body conducting the hearing”Map →
PersonGreg Walden“Chairman of the Committee on Energy and Commerce”Map →
PersonGene Green“Ranking Member of the Subcommittee on Health”Map →
PersonMichael C Burgess“Chairman of the Subcommittee on Health”Map →
PersonNancy Pelosi“Member of Congress who provided testimony”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record